The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
about
miRNA expression in colon polyps provides evidence for a multihit model of colon cancerHuman colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative statesModulation of mismatch repair and genomic stability by miR-155EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeDeficient mismatch repair: Read all about it (Review)Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smokingDNA damage response genes and the development of cancer metastasisTelomeres and telomere dynamics: relevance to cancers of the GI tractThe association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population.Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instabilityDefective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.Gastrointestinal tract cancers: Genetics, heritability and germ line mutationsColorectal tumour microsatellite instability test results: perspectives from patients.Economic and Practical Factors in Diagnosing HNPCC Using Clinical Criteria, Immunohistochemistry and Microsatellite Instability Analysis.Prognostic and predictive significance of MSI in stages II/III colon cancer.Functional and clinical significance of variants localized to 8q24 in colon cancer.Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial.BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome.Lower gastrointestinal tract cancer predisposition syndromesPatient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.High-level microsatellite instability in appendiceal carcinomas.Clinical significance of mismatch repair gene expression in sporadic colorectal cancer.Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry.Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations.Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPKPrevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.Correlation of chromosomal instability, telomere length and telomere maintenance in microsatellite stable rectal cancer: a molecular subclass of rectal cancer.Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan.Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasmsAn MLH1 haplotype is over-represented on chromosomes carrying an HNPCC predisposing mutation in MLH1BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancerHereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer.The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumors
P2860
Q21135357-4F745631-D9EE-4867-B42D-0C45A42B7157Q21260380-198B0E4C-0B0A-4A90-AA4E-D9D9AC4FD030Q24612859-7133F8DA-9310-464A-ACB5-7FF92BF4288AQ24655053-37CAAD19-9CC1-4481-9FC6-3B935E7AA269Q26796491-08E8DF66-B94F-4D1D-9205-867A44C80549Q28219035-0ABCF836-BAD3-4FD6-9E45-E164764A596CQ28388312-62A97FB2-E5DB-4B94-A7BA-5CF8E8C386E5Q28394311-58EE1D55-298F-4F3E-89DB-E42963943543Q33343083-9D2B95BD-39C2-4390-BD44-9E17D879678DQ33521938-E466F79F-76F3-435A-88D1-B4B1417E3895Q33522197-AD040253-407C-455A-BB5F-94A343C573D6Q33586020-9BF09B2B-DA72-4DC0-B7C3-065FCA620038Q33599436-972061C7-AC6F-4315-97DF-226D1496869BQ33732288-22651E94-0B56-40C7-8496-06C92BDE3D4BQ33732330-39BF3BC3-F0FD-4801-9985-D72A523C401EQ33735239-583B82DD-7096-44B0-ABBB-793D32FB17BBQ33763482-6AF7E530-3576-4779-9FF5-091F0CC391E7Q33887066-3BCE1CDD-EF77-43EB-98C3-2571AD0AFB24Q33892091-F8C3542C-92B8-4453-9763-3943AB776E0BQ33906044-66048DB7-9E1D-4106-92D5-0F0DCCE39B49Q33920573-318924B4-F539-43A2-AB88-AB5B2921F287Q33947880-721A5DDE-B9D0-4F6E-AB9F-A03CEE6969FCQ34042268-0BB0C8A4-97FD-4B7F-8D52-10270ADCD92DQ34075085-C01141AF-C81C-434A-A574-CE2C5348992AQ34292357-7B152A4C-A4F5-4783-A866-1365D5942F6BQ34362289-78058A70-65FE-4BDD-BD25-81398FF23F49Q34633911-801F3423-01C2-4B28-B544-364855A512D7Q34801092-64A1A2F9-FBF6-4146-B262-7CC1386701BCQ34985439-63769458-B315-4511-99E2-B55F35CB6EE7Q35020439-1128BE1B-9DD5-4B66-8F16-F535E985152AQ35022384-1A5CC11E-36E3-4CAD-B962-8DF3FFC86CF1Q35053406-17174983-6292-46AF-AE6A-47C19829DC5BQ35069428-971AB37F-DB73-41DE-90A8-688193CD0C2CQ35399306-0A763729-80F1-4795-9C35-34FE171B2711Q35439545-506D8BD0-8A77-4FE9-9C42-C7C8C131C355Q35446668-0B6C1F08-B6F8-41CF-8FED-A99F566929C9Q35487013-6CF7DD62-C6E8-4162-AA16-DC2CF2570369Q35596287-3C9DB8ED-2F3A-4E90-9BBA-E10A6CF8978BQ35597944-AAC57DB9-88B9-4B9E-AA0F-E4C31008D1F8Q35608600-87494470-0B8B-464E-B754-447304FB08A5
P2860
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The frequency of hereditary de ...... elected colorectal carcinomas.
@ast
The frequency of hereditary de ...... elected colorectal carcinomas.
@en
The frequency of hereditary de ...... elected colorectal carcinomas.
@nl
type
label
The frequency of hereditary de ...... elected colorectal carcinomas.
@ast
The frequency of hereditary de ...... elected colorectal carcinomas.
@en
The frequency of hereditary de ...... elected colorectal carcinomas.
@nl
prefLabel
The frequency of hereditary de ...... elected colorectal carcinomas.
@ast
The frequency of hereditary de ...... elected colorectal carcinomas.
@en
The frequency of hereditary de ...... elected colorectal carcinomas.
@nl
P2093
P2860
P356
P1476
The frequency of hereditary de ...... elected colorectal carcinomas.
@en
P2093
C Walsh Vockley
D J Schaid
D J Tester
E R Christensen
K C Halling
L J Burgart
S K McDonnell
S N Thibodeau
P2860
P304
P356
10.1086/323658
P407
P577
2001-08-24T00:00:00Z